<DOC>
	<DOCNO>NCT01505296</DOCNO>
	<brief_summary>The objective compare progression Atrial Fib ( AF ) burden continuous monitoring patient recently diagnose paroxysmal AF treat catheter ablation ( PVI ) versus anti-arrhythmic drug ( AAD ) therapy .</brief_summary>
	<brief_title>Catheter Ablation Recently Diagnosed Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description>Randomized , multicenter clinical trial compare medical therapy ( Group I ) ablation therapy ( Group II ) . Randomization determine open seal envelope . All patient implant implantable loop recorder follow every three month .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<criteria>Patients recently diagnose paroxysmal AF eligible receive specific rhythm control therapy Previous treatment Class IC class III AAD Previous AF ablation procedure Congestive heart failure ( NYHA IIIIV functional class ) Left Ventricle ejection fraction le 35 % Left atrial diameter &gt; 55mm Unwillingness participate</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Catheter ablation</keyword>
</DOC>